EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

A simple validation and screening method for CRISPR/Cas9-mediated gene editing in mouse embryos to facilitate genetically modified mice production

Dawid Winiarczyk, Hossein Khodadadi iD, Paweł Leszczyński iD, Hiroaki Taniguchi iD

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0312722 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift PLOS ONE, 2025. Verfasst von Dawid Winiarczyk und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Embryology, Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Jastrzebiec, Poland. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Editing, Embryo, Mammalian. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowym Centrum Nauki, Narodowe Centrum Nauki.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR/Cas9) is a genome engineering method for generating site-specific editing in target genes in a variety of species. It is a common tool for generating mouse models of different diseases. However, detecting target modifications in mouse embryos can be time-consuming and expensive. Accordingly, developing a screening method to confirm gene modification may be useful. We propose herein an evaluation method (cleavage assay – CA) for CRISPR/Cas9-mediated gene editing in preimplantation mouse embryos that allows us to detect mutants efficiently and later on initiate in vivo production without the extensive number of samples needing to be sent for Sanger sequencing and animal usage. Our method is based on the inability of the RNP complex to recognize the target sequence after CRISPR-mediated genome editing due to modification of the target locus. It allows us to establish gene edited mice in a user-friendly fashion with a limited number of mice usage by confirming each step of CRISPR-mediated gene editing of mouse embryos and, therefore, can be considered as a supportive tool to existing procedures for verification of successful CRISPR/Cas9-mediated gene alterations in mouse embryos and further mutant production.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsGene EditingEmbryo, MammalianAnimalsMiceFemaleMice, TransgenicBlastocyst

Autor:innen und Institutionen

  • Department of Experimental Embryology, Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Jastrzebiec, Poland.
  • Department of Stem Cell Bioengineering, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.
  • African Genome Center, Mohammed VI Polytechnic University (UM6P), Ben Guerir, Morocco.

ORCID-Profile: Hossein Khodadadi, Paweł Leszczyński, Hiroaki Taniguchi

Förderung

  • Narodowym Centrum Nauki
  • Narodowe Centrum Nauki

Zitieren

APA

Winiarczyk, D., Khodadadi, H., Leszczyński, P., & Taniguchi, H. (2025). A simple validation and screening method for CRISPR/Cas9-mediated gene editing in mouse embryos to facilitate genetically modified mice production. PLOS ONE. https://doi.org/10.1371/journal.pone.0312722

Vancouver

Winiarczyk D, Khodadadi H, Leszczyński P, Taniguchi H. A simple validation and screening method for CRISPR/Cas9-mediated gene editing in mouse embryos to facilitate genetically modified mice production. PLOS ONE. 2025. doi:10.1371/journal.pone.0312722

BibTeX
@article{Winiarczyk2025,
  author = {Winiarczyk, Dawid and Khodadadi, Hossein and Leszczyński, Paweł and Taniguchi, Hiroaki},
  title = {A simple validation and screening method for CRISPR/Cas9-mediated gene editing in mouse embryos to facilitate genetically modified mice production},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0312722}
}
Kostenlos starten →